Trial Profile
To Evaluate the efficacy and safety of the ustekinumab in korean patients with moderate to severe psoriasis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 21 Aug 2015
Price :
$35
*
At a glance
- Drugs Ustekinumab (Primary)
- Indications Psoriasis
- Focus Therapeutic Use
- 21 Aug 2015 New trial record